FIELD: medicine.
SUBSTANCE: invention relates to the use of a compound corresponding to the general structure (I) for the treatment, prevention or suppression of symptoms associated with at least one of the following: a) a mood disorder, including depression; and b) headache and/or migraine.
EFFECT: technical result: compounds such as amide derivatives of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid or 2-hydroxy-2-methyl-4-(3,5,6-trimethyl-1,4-benzoquinone-2-yl)butanoic acid, can effectively suppress the symptoms of mood disorders, as well as reduce the occurrence of headaches and migraines.
11 cl, 1 tbl, 1 ex
(I) where T corresponds either to structure (IIIa) or (IIIb):
(IIIa)
(IIIb)
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOUNDS AS mPGES-1 INHIBITORS | 2018 |
|
RU2793330C2 |
| INDOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2101283C1 |
| ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
| ALPHA-AMINOAMIDE DERIVATIVES USED AS ANTIMIGRAINE AGENTS | 2003 |
|
RU2336077C2 |
| METHODS OF PRODUCING CONJUGATES | 2012 |
|
RU2621035C2 |
| AMINO ACID LIPIDS | 2013 |
|
RU2670618C2 |
| PRODRUGS OF NONSTEROID ANTI-INFLAMMATORY AGENTS (NSAIA) WITH VERY HIGH SPEED OF PENETRATION THROUGH SKIN AND MEMBRANES, AND NEW MEDICAL APPLICATIONS OF ABOVE SAID PRODRUGS | 2007 |
|
RU2509076C2 |
| PYRAZINES APPLICABLE AS DELTA-OPIOID RECEPTOR MODULATORS | 2010 |
|
RU2543484C2 |
| IONTOPHORETIC DELIVERY OF ANTIMIGRAINE PREPARATION | 1994 |
|
RU2166315C2 |
| PRODRUG CONTAINING SELF-CLEAVABLE LINKER | 2014 |
|
RU2676324C2 |
